Carmell Corp Files Definitive Proxy Statement
Ticker: XAGEW · Form: DEF 14A · Filed: Jun 14, 2024 · CIK: 1842939
| Field | Detail |
|---|---|
| Company | Carmell Corp (XAGEW) |
| Form Type | DEF 14A |
| Filed Date | Jun 14, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.0001, $1.235 b, $1 billion, $700 million, $100 million |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Carmell Corp filed its proxy statement, shareholders vote soon.
AI Summary
Carmell Corp. filed a definitive proxy statement (DEF 14A) on June 14, 2024, for its annual meeting of stockholders. The company, formerly known as Carmell Therapeutics Corp and Alpha Healthcare Acquisition Corp III, is headquartered in Pittsburgh, PA, and operates in the surgical and medical instruments sector. The filing is related to the 1934 Securities Exchange Act.
Why It Matters
This filing is crucial for shareholders as it outlines the agenda and proposals for the company's annual meeting, influencing corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial information or strategic shifts.
Key Players & Entities
- Carmell Corp (company) — Registrant
- Carmell Therapeutics Corp (company) — Former company name
- ALPHA HEALTHCARE ACQUISITION CORP III (company) — Former company name
- 2403 SIDNEY STREET, SUITE 300 (location) — Business and Mail Address
- PITTSBURGH (location) — City
- PA (location) — State
- 15203 (location) — ZIP Code
- 412-894-8248 (phone_number) — Business Phone
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is filed by a company with the SEC to provide shareholders with information about matters to be voted on at an annual or special meeting of shareholders.
When was this DEF 14A filed?
This DEF 14A filing was filed on June 14, 2024.
What is Carmell Corp's primary business?
Carmell Corp's Standard Industrial Classification is 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]'.
What were Carmell Corp's previous names?
Carmell Corp was formerly known as Carmell Therapeutics Corp and before that, ALPHA HEALTHCARE ACQUISITION CORP III.
Where is Carmell Corp located?
Carmell Corp's business and mailing address is 2403 Sidney Street, Suite 300, Pittsburgh, PA 15203.
Filing Stats: 4,768 words · 19 min read · ~16 pages · Grade level 11.7 · Accepted 2024-06-14 08:24:41
Key Financial Figures
- $0.0001 — 7,757 shares of common stock, par value $0.0001 per share, of the Company (“comm
- $1.235 b — total annual gross revenue of at least $1.235 billion, or (c) following the fifth anniv
- $1 billion — date on which we have issued more than $1 billion in non-convertible debt in the prior th
- $700 million — ock held by non-affiliates is less than $700 million and our annual revenue was less than $1
- $100 million — on and our annual revenue was less than $100 million during the most recently completed fisc
- $250 million — ock held by non-affiliates is less than $250 million or (ii) our annual revenue was less tha
Filing Documents
- 2024_proxy_statement.htm (DEF 14A) — 557KB
- img261556127_0.jpg (GRAPHIC) — 8KB
- img261556127_1.jpg (GRAPHIC) — 415KB
- img261556127_2.jpg (GRAPHIC) — 369KB
- 0000950170-24-073350.txt ( ) — 1649KB
Security Ownership of Certain Beneficial Owners, Executive Officers, and Directors
Security Ownership of Certain Beneficial Owners, Executive Officers, and Directors 21 Certain Relationships and Related Party Transactions 22 Audit Committee Report 25 Proposal 2: Ratification of the Selection of Independent Registered Public Accounting Firm 26 Stockholder Proposals 27 Important Notice Regarding Delivery of Stockholder Documents 27 Other Business 27 CARMELL CORPORATION 2403 Sidney Street, Suite 300 Pittsburgh, Pennsylvania 15203 PROXY STATEMENT FOR THE 2024 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON July 12, 2024 AT 11:00 AM ET GENERAL INFORMATION The accompanying proxy is being solicited by the Board of Directors (the “Board”) of Carmell Corporation (“we,” “our,” “us,” the “Company” or “Carmell”) to be voted at the 2024 Annual Meeting of Stockholders of the Company (the “Annual Meeting”) to be held on Friday, July 12, 2024 at 11:00 a.m., Eastern Time, via live webcast at www.virtualshareholdermeeting.com/ctcx2024 . This proxy statement summarizes information that is intended to assist you in making an informed decision on the proposals described in this proxy statement. When are this proxy statement and the accompanying materials scheduled to be sent to stockholders? On or about June 13, 2024, we will begin mailing to our stockholders this proxy statement and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as amended (the “Annual Report”). This proxy statement also instructs you on how to submit your proxy or voting instructions through the internet, by telephone or by using the enclosed proxy card or voting instruction form that includes instructions on how to submit your proxy or voting instructions by mail or telephone. For shares held in street name (held for your account by a broker or other nominee), you will receive a voting instruction form from your broke